Leadership Move at Cipla: Achin Gupta Named MD & Global CEO-Designate, P. R. Ramesh for Reappointment
Cipla has proposed Achin Gupta as Managing Director and Global CEO while P. R. Ramesh is set to be reappointed as Director, signaling continuity in leadership at the pharmaceutical major.
Punita Thakur 
Leadership Move at Cipla: Achin Gupta Named MD & Global CEO-Designate, P. R. Ramesh for Reappointment
Cipla has proposed the appointment of Achin Gupta as the company’s Managing Director and Global Chief Executive Officer. The proposal marks a significant leadership development for the pharmaceutical giant as it continues to strengthen its strategic direction and global presence. Alongside this development, the company has also proposed the reappointment of P. R. Ramesh as Director, ensuring continuity in the organisation’s leadership and governance structure.
Strengthening Leadership
Gupta has been closely associated with Cipla’s leadership team and has contributed to the company’s strategic and financial growth. His proposed appointment reflects the organisation’s focus on long‑term stability and experienced leadership. If approved, Gupta will lead the company’s overall operations, global strategy, and expansion initiatives across key international markets.
Continuity at the Board Level
The reappointment of P. R. Ramesh is expected to reinforce Cipla’s governance framework and board expertise. His continued presence on the board will support the company’s ongoing transformation and long‑term growth plans. With these leadership developments, Cipla aims to further strengthen its position in the global pharmaceutical industry while maintaining strong corporate governance and strategic momentum.
